Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: A close linkage with obesity and length of the disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Coimbra, Susana ^a,b   Brandão Proença, Jorge ^b   Santos Silva, Alice ^a,c   Neuparth, Maria João ^b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHEMERIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; ADIPOQ PROTEIN, HUMAN; CHEMERIN, HUMAN; CHEMOKINE;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUALITY OF LIFE; AGE; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS; INSULIN RESISTANCE; TIME; VERY ELDERLY;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BODY MASS INDEX; CHEMOKINES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; OBESITY; TIME FACTORS;

EID: 84904809376     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/701915     Document Type: Article

References (50)

1. Cowie C. C., Rust K. F., Ford E. S., Eberhardt M. S., Byrd-Holt D. D., Li C., Williams D. E., Gregg E. W., Bainbridge K. E., Saydah S. H., Geiss L. S., Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009 32 2 287 294 10.2337/dc08-1296 2-s2.0-61849170118
2. Resnick H. E., Harris M. I., Brock D. B., Harris T. B., American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000 23 2 176 180 10.2337/diacare.23.2.176 2-s2.0-0033964010 (Pubitemid 30071020)
3. Ginter E., Simko V., Diabetes type 2 pandemic in 21st century. Bratislavské lekárske listy 2010 111 3 134 137 2-s2.0-77952980259
4. Koh-Banerjee P., Wang Y., Hu F. B., Spiegelman D., Willett W. C., Rimm E. B., Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. American Journal of Epidemiology 2004 159 12 1150 1159 10.1093/aje/kwh167 2-s2.0-2942544306 (Pubitemid 38747262)
5. Walker S. P., Rimm E. B., Ascherio A., Kawachi I., Stampfer M. J., Willett W. C., Body size and fat distribution as predictors of stroke among US men. The American Journal of Epidemiology 1996 144 12 1143 1150 10.1093/oxfordjournals.aje.a008892 2-s2.0-0029847412 (Pubitemid 26415104)
6. Nicklas B. J., Cesari M., Penninx B. W. J. H., Kritchevsky S. B., Ding J., Newman A., Kitzman D. W., Kanaya A. M., Pahor M., Harris T. B., Abdominal obesity is an independent risk factor for chronic heart failure in older people. Journal of the American Geriatrics Society 2006 54 3 413 420 10.1111/j.1532-5415.2005.00624.x 2-s2.0-33644657021 (Pubitemid 43327152)
7. Rondinone C. M., Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006 29 1 81 90 10.1385/ENDO:29:1:81 2-s2.0-33646873050 (Pubitemid 43780349)
8. Combs T. P., Berg A. H., Obici S., Scherer P. E., Rossetti L., Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. The Journal of Clinical Investigation 2001 108 12 1875 1881 10.1172/JCI200114120 2-s2.0-0035663963 (Pubitemid 34015133)
9. Tilg H., Moschen A. R., Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clinical Science 2008 114 3-4 275 288 10.1042/CS20070196 2-s2.0-38949106690 (Pubitemid 351294003)
10. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 6505 425 432 10.1038/372425a0 2-s2.0-0028139089 (Pubitemid 24365442)
11. Santos-Alvarez J., Goberna R., Sánchez-Margalet V., Human leptin stimulates proliferation and activation of human circulating monocytes. Cellular Immunology 1999 194 1 6 11 10.1006/cimm.1999.1490 2-s2.0-0033602850 (Pubitemid 29283971)
12. Tanaka T., Tsutamoto T., Nishiyama K., Sakai H., Fujii M., Yamamoto T., Horie M., Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure. Circulation Journal 2008 72 4 563 568 10.1253/circj.72.563 2-s2.0-43549099489 (Pubitemid 351679407)
13. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1595 1599 10.1161/01.ATV.20.6.1595 2-s2.0-0034096988 (Pubitemid 30353893)
14. Bahceci M., Gokalp D., Bahceci S., Tuzcu A., Atmaca S., Arikan S., The correlation between adiposity and adiponectin, tumor necrosis factor α interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? Journal of Endocrinological Investigation 2007 30 3 210 214 10.1007/BF03347427 2-s2.0-34250628015 (Pubitemid 46929320)
15. Boden G., Chen X., Mozzoli M., Ryan I., Effect of fasting on serum leptin in normal human subjects. The Journal of Clinical Endocrinology & Metabolism 1996 81 9 3419 3423 10.1210/jc.81.9.3419 2-s2.0-0029844267 (Pubitemid 26296227)
16. Neuparth M. J., Proenca J. B., Santos-Silva A., Coimbra S., Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes. ISRN Obesity 2013 2013 7 142097 10.1155/2013/142097
17. Snijder M. B., Heine R. J., Seidell J. C., Bouter L. M., Stehouwer C. D. A., Nijpels G., Funahashi T., Matsuzawa Y., Shimomura I., Dekker J. M., Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women the hoorn study. Diabetes Care 2006 29 11 2498 2503 10.2337/dc06-0952 2-s2.0-33845499740 (Pubitemid 44912259)
18. Roh S., Song S., Choi K., Katoh K., Wittamer V., Parmentier M., Sasaki S., Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications 2007 362 4 1013 1018 10.1016/j.bbrc.2007.08.104 2-s2.0-34548572409 (Pubitemid 47390675)
19. Goralski K. B., McCarthy T. C., Hanniman E. A., Zabel B. A., Butcher E. C., Parlee S. D., Muruganandan S., Sinal C. J., Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 2007 282 38 28175 28188 10.1074/jbc.M700793200 2-s2.0-34948836879 (Pubitemid 47529521)
20. Ernst M. C., Issa M., Goralski K. B., Sinal C. J., Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010 151 5 1998 2007 10.1210/en.2009-1098 2-s2.0-77953156149
21. Tönjes A., Fasshauer M., Kratzsch J., Stumvoll M., Bluher M., Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010 5 11 e13911 10.1371/journal.pone.0013911 2-s2.0-78649737080
22. Graessler J., Gruber M., Radke R., Kopprasch S., Schwarz P. E. H., Kamke W., Bornstein S. R., Fischer S., Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin. Gerontology 2011 57 4 316 326 10.1159/000316575 2-s2.0-79959655026
23. Okamoto Y., Arita Y., Nishida M., Muraguchi M., Ouchi N., Takahashi M., Igura T., Inui Y., Kihara S., Nakamura T., Yamashita S., Miyagawa J., Funahashi T., Matsuzawa Y., An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Hormone and Metabolic Research 2000 32 2 47 50 10.1055/s-2007-978586 2-s2.0-0034014647 (Pubitemid 30143606)
24. Laughlin G. A., Barrett-Connor E., May S., Langenberg C., Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. American Journal of Epidemiology 2007 165 2 164 174 10.1093/aje/kwk001 2-s2.0-33846221186 (Pubitemid 46096378)
25. Wannamethee S. G., Whincup P. H., Lennon L., Sattar N., Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Archives of Internal Medicine 2007 167 14 1510 1517 10.1001/archinte.167.14.1510 2-s2.0-34547179430 (Pubitemid 47124181)
26. Pilz S., Mangge H., Wellnitz B., Seelhorst U., Winkelmann B. R., Tiran B., Boehm B. O., März W., Adiponectin and mortality in patients undergoing coronary angiography. Journal of Clinical Endocrinology and Metabolism 2006 91 11 4277 4286 10.1210/jc.2006-0836 2-s2.0-33751515431 (Pubitemid 44833399)
27. Enriori P. J., Evans A. E., Sinnayah P., Cowley M. A., Leptin resistance and obesity. Obesity 2006 14 supplement 5 254S 258S 10.1038/oby.2006.319 2-s2.0-34250845880
28. Bozaoglu K., Segal D., Shields K. A., Cummings N., Curran J. E., Comuzzie A. G., Mahaney M. C., Rainwater D. L., Vandeberg J. L., MacCluer J. W., Collier G., Blangero J., Walder K., Jowett J. B. M., Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. The Journal of Clinical Endocrinology & Metabolism 2009 94 8 3085 3088 10.1210/jc.2008-1833 2-s2.0-68549109421
29. Stejskal D., Karpisek M., Hanulova Z., Svestak M., Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomedical papers of the Medical Faculty of the University Palacký Olomouc, Czechoslovakia 2008 152 2 217 221 10.5507/bp.2008.033 2-s2.0-62449203154
30. Chakaroun R., Raschpichler M., Klöting N., Oberbach A., Flehmig G., Kern M., Schön M. R., Shang E., Lohmann T., Dreßler M., Fasshauer M., Stumvoll M., Blüher M., Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism: Clinical and Experimental 2012 61 5 706 714 10.1016/j.metabol.2011.10.008 2-s2.0-84860253304
31. Schmidt M. I., Duncan B. B., Vigo A., Pankow J. S., Couper D., Ballantyne C. M., Hoogeveen R. C., Heiss G., Leptin and incident type 2 diabetes: risk or protection? Diabetologia 2006 49 9 2086 2096 10.1007/s00125-006-0351-z 2-s2.0-33746696655 (Pubitemid 44168476)
32. Isobe T., Saitoh S., Takagi S., Takeuchi H., Chiba Y., Katoh N., Shimamoto K., Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. European Journal of Endocrinology 2005 153 1 91 98 10.1530/eje.1.01930 2-s2.0-22744449154 (Pubitemid 41030520)
33. Adamczak M., Rzepka E., Chudek J., Wiecek A., Ageing and plasma adiponectin concentration in apparently healthy males and females. Clinical Endocrinology 2005 62 1 114 118 10.1111/j.1365-2265.2004.02182.x 2-s2.0-12944289732 (Pubitemid 40175291)
34. Vilarrasa N., Vendrell J., Maravall J., Broch M., Estepa A., Megia A., Soler J., Simón I., Richart C., Gómez J. M., Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clinical Endocrinology 2005 63 3 329 335 10.1111/j.1365-2265.2005. 02346.x 2-s2.0-24144498663 (Pubitemid 41233452)
35. McEntegart M. B., Awede B., Petrie M. C., Sattar N., Dunn F. G., MacFarlane N. G., McMurray J. J. V., Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. European Heart Journal 2007 28 7 829 835 10.1093/eurheartj/ehm033 2-s2.0-34548355070 (Pubitemid 47343601)
36. Tsunekawa T., Hayashi T., Suzuki Y., Matsui-Hirai H., Kano H., Fukatsu A., Nomura N., Miyazaki A., Iguchi A., Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care 2003 26 2 285 289 10.2337/diacare.26.2.285 2-s2.0-0042593396 (Pubitemid 36929044)
37. Wannamethee S. G., Lowe G. D. O., Rumley A., Cherry L., Whincup P. H., Sattar N., Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007 30 5 1200 1205 10.2337/dc06-2416 2-s2.0-34247636175 (Pubitemid 46684648)
38. Isidori A. M., Strollo F., Moré M., Caprio M., Aversa A., Moretti C., Frajese G., Riondino G., Fabbri A., Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. The Journal of Clinical Endocrinology & Metabolism 2000 85 5 1954 1962 10.1210/jc.85.5.1954 2-s2.0-0034457109 (Pubitemid 32269305)
39. Bruunsgaard H., Pedersen A. N., Schroll M., Skinhoj P., Pedersen B. K., TNF- α leptin, and lymphocyte function in human aging. Life Sciences 2000 67 22 2721 2731 10.1016/S0024-3205(00)00851-1 2-s2.0-0034692868
40. Koistinen H. A., Koivisto V. A., Karonen S.-L., Rönnemaa T., Tilvis R. S., Serum leptin and longevity. Aging 1998 10 6 449 454 10.1007/BF03340158 2-s2.0-0032466282
41. Agrawal A., Lourenco E. V., Gupta S., La Cava A., Gender-based differences in leptinemia in healthy aging, non-obese individuals associate with increased marker of oxidative stress. International Journal of Clinical and Experimental Medicineis 2008 1 4 305 309
42. Lambrinoudaki I., Christodoulakos G., Panoulis C., Botsis D., Rizos D., Augoulea A., Creatsas G., Determinants of serum leptin levels in healthy postmenopausal women. Journal of Endocrinological Investigation 2003 26 12 1225 1230 10.1007/BF03349162 2-s2.0-1542376061 (Pubitemid 38324742)
43. van den Saffele J. K., Goemaere S., de Bacquer D., Kaufman J. M., Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency? Clinical Endocrinology 1999 51 1 81 88 10.1046/j.1365-2265.1999.00741.x 2-s2.0-0032787635 (Pubitemid 29339539)
44. Sanchez-Rodriguez M., Garcia-Sanchez A., Retana-Ugalde R., Mendoza-Nunez V. M., Serum leptin levels and blood pressure in the overweight elderly. Archives of Medical Research 2000 31 4 425 428 10.1016/S0188-4409(99)00079-X 2-s2.0-0033785401
45. Qiu J., Ogus S., Lu R., Chehab F. F., Transgenic mice overexpressing leptin accumulate adipose mass at an older, but not younger, age. Endocrinology 2001 142 1 348 358 10.1210/en.142.1.348 2-s2.0-0035111334 (Pubitemid 32183696)
46. Maggio M., Lauretani F., Ceda G. P., Bandinelli S., Basaria S., Ble A., Egan J., Paolisso G., Najjar S., Jeffrey Metter E., Valenti G., Guralnik J. M., Ferrucci L., Association between hormones and metabolic syndrome in older Italian men. Journal of the American Geriatrics Society 2006 54 12 1832 1838 10.1111/j.1532-5415.2006.00963.x 2-s2.0-33845489807 (Pubitemid 44915825)
47. Milaneschi Y., Simonsick E. M., Vogelzangs N., Strotmeyer E. S., Yaffe K., Harris T. B., Tolea M. I., Ferrucci L., Penninx B. W. J. H., Leptin, abdominal obesity, and onset of depression in older men and women. Journal of Clinical Psychiatry 2012 73 9 1205 1211 10.4088/JCP.11m07552 2-s2.0-84866520999
48. Labad J., Price J. F., Strachan M. W. J., Deary I. J., Seckl J. R., Sattar N., Reynolds R. M., Serum leptin and cognitive function in people with Type 2 diabetes. Neurobiology of Aging 2012 33 12, article e2 2938 2941 10.1016/j.neurobiolaging.2012.02.026 2-s2.0-84866772892
49. Aronis K. N., Sahin-Efe A., Chamberland J. P., Spiro A. III, Vokonas P., Mantzoros C. S., Chemerin levels as predictor of acute coronary events: a case-control study nested within the veterans affairs normative aging study. Metabolism 2014 63 6 760 766 10.1016/j.metabol.2014.02.013
50. Neuparth M. J., Proenca J. B., Santos-Silva A., Coimbra S., The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. Journal of Investigative Medicine 2014 62 2 350 353